The global pharmaceutical industry relies heavily on a robust supply of specialized chemical intermediates to drive innovation and produce life-saving medicines. Among these essential compounds is 4-(2,2-Dichlorocyclopropyl)phenol 1-acetate, identified by its CAS number 144900-34-5. NINGBO INNO PHARMCHEM CO.,LTD, a prominent player in this sector, is committed to supplying this high-purity white powder, recognizing its critical role in pharmaceutical synthesis.

This intermediate is particularly valued for its application in the creation of hypolipidemic agents, with Ciprofibrate being a notable example. The synthesis of such complex pharmaceuticals requires intermediates that meet rigorous purity standards, often exceeding 99%. NINGBO INNO PHARMCHEM CO.,LTD ensures that its 4-(2,2-Dichlorocyclopropyl)phenol 1-acetate meets these exacting requirements, providing a reliable foundation for drug manufacturers. The company's ability to produce 500 metric tons annually underscores its capacity to support large-scale production demands.

For businesses in the chemical and pharmaceutical sectors looking to buy or purchase this intermediate, understanding its applications and the advantages of sourcing from a reputable supplier is key. NINGBO INNO PHARMCHEM CO.,LTD offers competitive pricing and leverages its strong R&D and production capabilities to ensure product quality and timely delivery. Their expertise in chemical manufacturing, combined with over 15 years of export experience, makes them an ideal partner for companies seeking consistent quality and efficient supply chain management for their pharmaceutical intermediate needs.

The meticulous process of drug development necessitates the use of intermediates like 4-(2,2-Dichlorocyclopropyl)phenol 1-acetate, which are produced under strict quality controls. NINGBO INNO PHARMCHEM CO.,LTD's dedication to maintaining high standards in the production of this essential compound reflects their broader commitment to contributing to global health through reliable chemical supply.